6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A case report of coronary artery aneurysms with restenosis and stent fractures developed 14 years after sirolimus eluting stents implantation successfully treated with drug-coated balloons

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Coronary aneurysms following drug-eluting stent implantation are rare but associated with adverse events.

          Case summary

          An 80-year-old male admitted to our hospital with resting chest discomfort. He had undergone percutaneous coronary interventions (PCIs) with first-generation sirolimus-eluting stent (SES) implantation to the right coronary artery (RCA) and left anterior descending artery (LAD) 14 years ago. Coronary angiography revealed coronary aneurysms and stent fractures in the RCA and LAD where SES was implanted. The aneurysm sizes of the RCA and LAD were 7 × 8 and 7 × 10 mm, respectively. Moreover, in-stent restenosis (ISR) with ischaemia were found in the LAD. The patient was at high risk for cardiac surgery and the coronary aneurysms were not suitable for percutaneous interventions. Therefore, we treated only ISR lesions using drug-coated balloons (DCBs) without intervention for coronary aneurysms. Intravascular ultrasound (IVUS) revealed that the first guide wire went outside the malapposed stents. After rewiring using a double-lumen microcatheter with another guide wire, IVUS confirmed the second guide wire passed entirely inside the stents. Then, the ISR lesions were dilated with high-pressure balloons and DCBs. The post-procedural course was uneventful and his symptoms were relieved.

          Discussion

          This case demonstrated coronary aneurysms with ISR and stent fractures 14 years after SES implantation. Depending on patient background and lesion morphology, DCB can be one of the treatment options. Intravascular imaging is useful to guide PCI in patients with coronary aneurysms.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Coronary artery aneurysms after drug-eluting stent implantation.

          Drug-eluting stents (DES), which locally elute antiproliferative drugs, can dramatically inhibit neointimal growth. However, several pathological studies have indicated that DES may delay healing after vascular injury, and DES implantation may be theoretically associated with a risk of coronary artery aneurysm formation. Coronary aneurysms have been reported from 3 days to up to 4 years after DES implantation procedures, with varying clinical presentations. The incidence of coronary artery aneurysms after DES implantation is low within the first 9 months, with a reported incidence of 0.2% to 2.3%, a rate similar to that reported after bare-metal stent (BMS) implantation (0.3% to 3.9%) in the DES versus BMS randomized trials. However, the true incidence of coronary aneurysms in an unselected patient population is still largely unknown. This article reviews the published literature on coronary artery aneurysms specifically relating to DES.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings.

            This study sought to assess clinical, angiographic, and intravascular ultrasound (IVUS) findings in patients developing coronary aneurysms (CANs) after drug-eluting stent (DES) implantation. The long-term safety of DES remains unsettled. This study analyzed 1,197 consecutive patients with late angiographic evaluation after DES implantation. In 15 patients (1.25%, 95% confidence interval: 0.58 to 1.93), CANs developed at follow-up. Analyses included quantitative angiography and volumetric IVUS. DES developing CANs were more frequently implanted during acute myocardial infarction and were longer than those without this outcome. The elapsed time from DES implantation to CAN diagnosis was 313 +/- 194 days. Angiographically, maximal CAN diameter measured 5.1 +/- 1.2 mm. On IVUS, CAN external elastic lamina area was 32 +/- 13.1 mm(2) and incomplete apposition area was 12.1 +/- 8.6 mm(2). Two patients presented with acute myocardial infarction secondary to DES thrombosis. Four additional patients presented with unstable angina and underwent CAN aggressive dilation (3 were also treated for concomitant in-stent restenosis). Dual antiplatelet therapy was recommended in the remaining 9 patients who were asymptomatic at CAN diagnosis, but 1 of them eventually died of cardiogenic shock after a CAN-related myocardial infarction. After a mean follow-up of 399 +/- 347 days, the 1-year event-free survival was 49 +/- 14% and was related to CAN size on IVUS. In 2 patients, CANs disappeared at repeated late angiography and IVUS showed abluminal CAN thrombosis. After DES implantation, CANs are rare and may be detected in asymptomatic patients. However, CANs are frequently associated with adverse clinical events as a result of DES restenosis and DES thrombosis. Further studies are required to determine the implications of this distinct new entity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture.

              We sought to examine the intravascular ultrasound (IVUS) findings of stent fracture. Stent fracture has been implicated as a cause of drug-eluting stent failure. IVUS is more likely to identify mechanisms of stent failure -- including stent fracture -- than angiography. Twenty stent fractures diagnosed by IVUS in 17 patients were evaluated. Eighteen stent fractures (90%) occurred in sirolimus-eluting Cypher stents, and 2 stent fractures (10%) occurred in bare metal stents, but none occurred in paclitaxel-eluting Taxus stents. Half of the stent fractures presented 1 year after implantation. IVUS analysis showed that 9 stent fractures were complete (45%) and 11 were partial (55%); 10 (50%) were adjacent to stent metal overlap; and 5 occurred in a coronary aneurysm accompanied by malapposition (all Cypher stents) despite the absence of an aneurysm at index stenting. Compared with 60 matched control segments in patients without stent fracture, but with similar clinical events, the stent fracture group had longer stent segments (45.2 +/- 23.0 vs 28.5 +/- 14.9 mm, p = 0.003). Comparing stent fractures associated with an aneurysm (n = 5) with those that did not occur in association with an aneurysm (n = 15) showed that complete stent fracture was more frequent (100% vs 27%, p = 0.008), and all presented >1 year after index stenting (vs 33%, p = 0.03). In conclusion, IVUS is helpful to identify stent fracture as a cause of stent failure and to understand possible mechanisms of stent fracture such as aneurysm formation.
                Bookmark

                Author and article information

                Contributors
                Role: Handling Editor
                Role: Editor
                Role: Editor
                Role: Editor
                Journal
                Eur Heart J Case Rep
                Eur Heart J Case Rep
                ehjcr
                European Heart Journal: Case Reports
                Oxford University Press (US )
                2514-2119
                February 2024
                29 January 2024
                29 January 2024
                : 8
                : 2
                : ytae050
                Affiliations
                Department of Cardiovascular Medicine, Japanese Red Cross Wakayama Medical Center , 4-20 Komatsubara-dori, Wakayama 640-8558, Japan
                Department of Cardiovascular Medicine, Japanese Red Cross Wakayama Medical Center , 4-20 Komatsubara-dori, Wakayama 640-8558, Japan
                Department of Cardiovascular Medicine, Japanese Red Cross Wakayama Medical Center , 4-20 Komatsubara-dori, Wakayama 640-8558, Japan
                Author notes
                *Corresponding author. Tel: +81 73 422 4171, Fax: +81 73 426 1168, Email: takanari.fujita0427@ 123456gmail.com

                Conflict of interest: None declared.

                Author information
                https://orcid.org/0000-0003-4948-9989
                Article
                ytae050
                10.1093/ehjcr/ytae050
                10852020
                38332918
                e21bf336-8f26-4f8f-afea-8b4885379c50
                © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 October 2023
                : 20 January 2024
                : 24 January 2024
                : 08 February 2024
                Page count
                Pages: 5
                Categories
                Case Report
                Coronary Intervention
                AcademicSubjects/MED00200
                Eurheartj/39
                Eurheartj/41
                Eurheartj/15
                Eurheartj/18
                Eurheartj/31
                Eurheartj/32

                case report,coronary artery aneurysm,percutaneous coronary intervention,drug-coated balloon,drug-eluting stent,in-stent restenosis

                Comments

                Comment on this article